Clinical trialNCT01858480WithdrawnPhase 2Interventional

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

SponsorRiboCor, Inc.Enrollment0Congestive Heart Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the safety and to determine the efficacy of D-ribose for the treatment of congestive heart failure (CHF) in subjects who have been stabilized following hospitalization with acute decompensation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Wilson S Colucci, MD
Boston University
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

St. Michael'S Hospital
Toronto, Ontario, Canada
Chum Hotel Dieu
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Montreal General Hospital / Muhc
Montreal, Quebec, Canada

United States

Long Beach Memorial Medical Center
Long Beach, California, United States
Novo Research, Inc.
Modesto, California, United States
Olive View-Ucla- Medical Center
Sylmar, California, United States
Harbor-Ucla Medical Center
Torrance, California, United States
Southeast Regional Research Group
Columbus, Georgia, United States
Mercer University - Mercer Medicine
Macon, Georgia, United States
Medical Consultants Pc
Muncie, Indiana, United States
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
Medpharmics
Kenner, Louisiana, United States
Androscoggin Cardiology Associates / Dba Maine Research Associates
Auburn, Maine, United States
University of Maryland, Baltimore
Baltimore, Maryland, United States
Genesys Regional Medical Ctr
Grand Blanc, Michigan, United States
University of Medicine and Dentistry of New Jersey
Newark, New Jersey, United States
Holy Name Medical Center
Teaneck, New Jersey, United States
Columbia University Medical Center
New York, New York, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
Oklahoma Foundation for Cardiovascular Research
Oklahoma City, Oklahoma, United States
Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
Baptist Clinical Research Institute
Memphis, Tennessee, United States
Michael Debakey Vamc
Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ribose

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2013
Primary completion: 30 Nov 2013
Completion: 30 Nov 2013
Last update posted: 14 Jul 2016
Registered enrollment: 0
Registry id: NCT01858480

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.